RE:Excellent NewsYes, this is excellent news!
Dr. Jewett understands Theralase's treatment inside and out. In 2018 he was the one who presented the Phase II clinical protocol and study design to the other members of Theralase's Medical and Scientific Advisory Board for review and approval.
In 2018 he was the chair of Theralase's MSAB and presented the upcoming phase 2 trial on a Business Television interview:
Dr. Jewett Interview on BTD At the 2019 AGM he presented an overview of the phase 2 trial. In the first half of the video Dr. Kulkarni presented the results of the Phase 1 study. Starting at 10 mins. 58 secs. Dr. Jewett provides a detailed description of the Phase 2.
Overview of Phase II Clinical Study A transcript of his presentation is available here:
Transcript of Dr. Jewett's Presentation at the June 2019 AGM